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ABSTRACT
Nanoparticles (NPs) are easily contaminated by bacterial endotoxin (lipopolysaccharide [LPS]).
The presence of LPS can be responsible for many immune/inflammatory effects attributed to
NPs. In this study, we examined the effects of LPS adsorption on the NP surface on the forma-
tion of a biocorona in biological fluids and on the subsequent inflammation-inducing activity of
NPs. Different gold (Au) NPs with sizes ranging from 10 to 80nm and with different surface func-
tionalization (sodium citrate, lipoic acid, and branched polyethyleneimine (BPEI), or polyethylene
glycol (PEG)) were exposed to E. coli LPS under different conditions. The binding capacity of LPS
to the surface of AuNPs was dose- and time-dependent. LPS attached to sodium citrate and
lipoic acid coatings, but did not adhere to BPEI- or PEG-coated NPs. By computational simulation,
the binding of LPS to AuNPs seems to follow the Langmuir absorption isotherm. The presence
of LPS on AuNP surface interfered and caused a decrease in the formation of the expected bio-
molecular corona upon incubation in human plasma. LPS-coated AuNPs, but not the LPS-free
NPs, induced significant inflammatory responses in vitro. Notably, while free LPS did also induce
an anti-inflammatory response, LPS bound to NPs appeared unable to do so. In conclusion, the
unintentional adsorption of LPS onto the NP surface can affect the biocorona formation and the
inflammatory properties of NPs. Thus, for an accurate interpretation of NP interactions with cells,
it is extremely important to be able to distinguish the intrinsic NP biological effects from those
caused by biologically active contaminants such as endotoxin.
ARTICLE HISTORY
Received 3 May 2017
Revised 8 September 2017
Accepted 27 October 2017
KEYWORDS
Nano-immunosafety; endo-
toxin contamination;
biocorona modulation; gold
nanoparticles; inflammatory
effects
Introduction
Due to the increased usage of nanomaterials for dif-
ferent applications, the safety aspects are of key
importance for ensuring their responsible use and
for sustaining their industrial development
(Savolainen et al. 2013). Nanosafety studies depend
on scientific reports on the biological effects of
nanoparticles (NPs) in living organisms, in order to
predict and correct the possible deleterious impact
on human and environmental health. Many studies
showed that NPs may have adverse effects on
health, mainly due to their small size, large surface
area per mass and highly reactive properties (Bastus
et al. 2008; Ge et al. 2012; Li et al. 2012; Wang et al.
2013). Among the different NP effects in biological
systems, activation of immune responses is consid-
ered a central element for assessing health risks of
NPs (Boraschi and Duschl 2012; Li et al. 2016).
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Reliability of the safety assays, both in vitro and
in vivo, implies the accurate characterization of the
nanomaterial being tested, which should be devoid
not only of chemical impurities but also of biologic-
ally active contaminants (Dobrovolskaia, Germolec,
and Weaver 2009; Li and Boraschi 2016). In this con-
text, the presence of an ubiquitous contaminant
such as bacterial endotoxin (lipopolysaccharide, LPS)
should be thoroughly assessed in newly developed
engineered NP preparations, since LPS is a robust,
persistent, ubiquitous, potent immune/inflammatory
activator, and toxic molecule, which is difficult to
detect in NPs (Li et al. 2015) and could be respon-
sible for the majority of inflammatory/toxic effects
generally attributed to engineered NPs (Li and
Boraschi 2016; Li, Fujita, and Boraschi 2017).
LPS is a major component of the outer cell mem-
brane of gram-negative bacteria, which potently
induces an inflammatory response in cells that
express Toll-like receptor 4 (TLR4). LPS binds to
the LPS-binding protein (LBP), which facilitates the
engagement with TLR4 and the formation of the
complex with CD14 and MD2, thereby initiating cell
activation. TLR4 is expressed on many cell types but
the most reactive cells are monocytes and macro-
phages, which in response to LPS are activated (M1
or classical activation) to become cytocidal and to
produce a variety of inflammatory factors such as
interleukin (IL)-1b, IL-6, IL-8, and tumor necrosis fac-
tor (TNF)-a (Li and Boraschi 2016). LPS can also be
found in the absence of live bacteria, and is present
in most chemicals and glassware in the laboratory
because it is heat stable and cannot be eliminated
by sterilization methods (Gorbet and Sefton 2005; Li
and Boraschi 2016). In previous studies, we showed
that different batches of NPs synthesized following
an identical protocol may have different contamin-
ation levels of endotoxin depending on the level of
cleanliness during the synthesis procedure
(Oostingh et al. 2011). Also, we found that poor
handling processes and storage under different con-
ditions can contaminate NPs and endow them with
an inflammatory potential (Murali et al. 2015). This
is a consequence of the fact that LPS can bind to
all kinds of surfaces and thus represents a ubiqui-
tous contaminant in all types of biomaterials
(Gorbet and Sefton 2005; Li and Boraschi 2016).
Darkow et al. showed that endotoxin can bind to
different surface-functionalized NPs, depending on
the NP ability to establish Coulomb and van der
Waals interactions with the endotoxin molecules
(Darkow et al. 1999). It has been reported that the
hydrophobic part of LPS (lipid A) binds to the surface
of latex particles, so that the resulting LPS-coated
particles could be used for agglutination immunoas-
says (Peula-Garcıa et al. 2002). Another study showed
that cobalt-based NPs have a strong affinity for lipid
A and suggested to use these NPs for the elimination
of E. coli bacteria from suspensions (Bromberg et al.
2010). Although many studies have shown the inter-
action of LPS with NPs and used this feature to
develop new technical applications, less attention
has been given to the influence of LPS contamin-
ation for nanosafety assessment. Even in the field of
nanomedicine, this topic has been underestimated
and there are numerous publications on the bio-
logical and immunological effects of NPs in which
LPS contamination was not assessed.
In this study, a set of different gold (Au) NPs,
spanning a size range between 10 and 80 nm and
with different surface functionalization was used to
investigate the interaction between LPS and NPs
and the consequent effects on biomolecular corona
formation. A computational method to simulate the
interaction between LPS and the Au NP surface was
also employed, in which we incorporated the
acquired experimental data to define a mathemat-
ical relationship between LPS and the Au NPs. The
goal of this study was to determine the inflamma-
tion-inducing capacity of LPS-coated NPs on human
monocytes in culture, and to compare it to
uncoated NPs and to free LPS.
Methods
Types of Au NPs used in this study
Sodium citrate-coated 10nm Au NPs (Au10CIT) were
synthesized by the wet chemistry method under con-
ditions that enabled the collection of stable and nar-
rowly dispersed NPs (Figure 1). Citrate-coated 50nm
Au NPs were purchased from Sigma-Aldrich Inc. (St.
Louis, MO, USA). The 40nm and 80nm lipoic acid
(Au40LIP and Au80LIP), 40nm branched polyethylenei-
mine (Au40BPEI), and 40nm polyethylene glycol
(Au40PEG)-coated Au NPs were custom-synthesized by
nanoComposix, Inc. (San Diego, CA, USA). Since the
commercial citrate-coated 50 nm Au NPs fell in the
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40-60nm size range of all the other 40nm Au NPs,
we defined them as Au40CIT. The detailed characteris-
tics are shown in Figure 1 and Table 1.
Au NP synthesis
The synthesis of Au10CIT was carried out starting
with metallic salt precursors either decomposed
or reduced in the presence of stabilizers.
Reagents were purchased from Sigma-Aldrich Inc.,
and used as received. In detail, Au10CIT were
obtained based on Turkevich et al. (Turkevich,
Stevenson, and Hillier 1955), i.e., by fast addition of
1ml hydrogen tetrachloroaurate (HAuCl4) 0.025M to
150ml of boiling trisodium citrate (SC) 2.2 103M
under vigorous stirring. After 3–5min, NPs
Table 1. Characteristics of Au NPs.
Stock concentrations
Name
Hydrodynamic
diameter (nm) pH mg/ml NPs/ml cm2/ml
Z-potential
(mV) Surface coating
LPS content
(EU/ml)
Au10CIT 10.4 ± 0.8 7 32 3.0 1012 10 67 Sodium citrate 0.45
Au40CIT 58.2 ± 0.8 7 1.14 3.5 1010 2.7 42 Sodium citrate 20
Au40LIP 46.0 ± 0.2 6 1080 1.6 1012 82 42 Lipoic acid <2.5
Au40BPEI 52.5 ± 0.2 7 1060 1.7 1012 81 67 BPEI <2.5
Au40PEG 61.9 ± 0.3 6 1010 1.4 1012 75 4.7 PEG <2.5
Au80LIP 91.1 ± 1.1 7 1060 1.9 1011 39 45 Lipoic acid <2.5
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Figure 1. Characterization of Au NPs. TEM, UV-VIS spectra and size distribution of the different types of Au NPs. (A) Au10CIT, (B)
Au40CIT, (C) Au40LIP, (D) Au40BPEI, (E) Au40PEG, and (F) Au80LIP. In the upper right corners are shown the chemical formulas of
citrate (A and B), lipoic acid (C and F), BPEI (D), and PEG (E).
NANOTOXICOLOGY 1159
developed a characteristic red color of the colloidal
gold and the solution was cooled down to room
temperature (RT). The resulting NPs were loosely
coated with negatively charged citrate anions acting
as stabilizers. The Au40CIT were purchased from
Sigma-Aldrich Inc., and synthesized based on Bastus
et al. (Bastus, Comenge, and Puntes 2011). The
other 40 nm and 80 nm Au NPs were obtained from
nanoComposix Inc., and their synthesis methods
were reported previously (Choi, Riviere, and
Monteiro-Riviere 2016; Li and Monteiro-Riviere
2016).
Au10CIT were synthesized using endotoxin-free
conditions (endotoxin-free water, depyrogenated
glassware), in order to minimize endotoxin contam-
ination of NPs (Li and Boraschi 2016). The endotoxin
contamination level of Au NPs was evaluated with
optimized procedures (see below).
NP characterization
NPs were fully characterized by different techniques,
i.e., transmission electron microscopy (TEM), zeta
potential (Z-potential), dynamic light scattering
(DLS) and UV-visible spectrophotometry (UV-VIS).
Transmission electron microscopy (TEM)
TEM micrographs were acquired with a JEOL 1010
electron microscope at an accelerating voltage of
80 kV. Samples for TEM were prepared by drop cast-
ing on carbon-coated cooper grids, then dried at
RT. Different areas of the grid were observed with
different magnifications, and more than 400 NPs
were computer-analyzed and measured for size
distribution.
LPS binding on the surface of Au NPs was char-
acterized by TEM. Samples were placed on the
coated copper grids directly after incubation and
examined unstained on a FEI Tecnai G2 Spirit BioT -
WIN TEM at an accelerating voltage of 120 kV.
Z-potential measurement and DLS
Measurements were made with a Malvern
ZetaSizer Nano ZS (Malvern Instruments, Malvern,
Worcestershire, UK) operating at a light source
wavelength of 532 nm and a fixed scattering angle
of 173, on 0.8ml aliquots of the colloidal NP sus-
pensions. The software was set with specific
parameters of refractive index and absorption coeffi-
cient of NP material and solvent viscosity, required
to obtain the correct value for each type of NP.
Zeta-potential (surface charge) measurements were
used to determine the stability of a colloidal sus-
pension of electrostatically stabilized NPs.
Conversely, DLS allows the determination of the
hydrodynamic diameters of colloidal particles and
conjugates, i.e., the diameter of the sphere with the
same Brownian motion as the particle under
analysis.
UV-Visible Spectrophotometry (UV-VIS)
UV-VIS spectra were acquired with a Shimadzu
UV-2400 spectrophotometer, on 1ml aliquots of the
NP suspension, and performing the spectral analysis
in the 300-800 nm range. This technique is used for
metallic NPs that exhibit a characteristic absorbance
maximum in the visible range (the surface plasmon
resonance, SPR), which changes depending on the
size and surface alterations. However, all materials
used absorb light in the visible or UV range, making
these measurements appropriate in all cases.
Endotoxin adhesion to NPs and interference with
biomolecular corona formation
One ml of the Au10CIT stock solution (32 lg/ml) was
exposed to different concentrations (0.3, 1.0, 3.3, and
10.0 lg/ml) of LPS from E. coli LPS O55:B5 (cat. n.
L6529, Sigma-Aldrich Inc.) at different temperatures
(4 C, RT and 37 C) at different time points. Au10CIT
were collected by ultracentrifugation at 36000g
for 40min. Two washing steps were performed with
endotoxin-free water to eliminate the unbound LPS.
One ml Au40CIT (3.5 105 NPs/ml) was incubated
with 5mg E. coli LPS overnight at 4 C. The excess
bystander LPS was removed by three washing steps
(5min at 18000 rpm). One ml of Au40LIP, Au40BPEI,
Au40PEG, or Au80LIP stock solutions (25 lg/ml) were
incubated with 1.0, 3.3, 10.0 lg/ml E. coli LPS over
time (up to 1week), collected at 14000g for
10min, and washed in endotoxin-free water to elim-
inate unbound LPS. Characteristics of these NP were
evaluated by UV-VIS, DLS, and TEM before and after
exposure to LPS.
For analysis of potential interference of LPS with
biomolecular corona formation, 25 lg/ml LPS-coated
Au40LIP (previously incubated with 10 lg/ml E. coli
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LPS for 2 h at RT and washed) were resuspended in
pooled human plasma that collected from healthy
donors (n¼ 5) (Biological Specialty Corporation, PA,
USA) and incubated at 37 C over time, and the size
variation due to the corona formation was analyzed
by DLS. For specifically investigating the formation
of a stable biomolecular corona, after 4 h incubation
with plasma at 37 C, NPs were centrifuged at 4 C
at 14000g for 10min and resuspended in PBS for
DLS characterization.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) analysis of
biomolecular corona proteins
Au40LIP (25 lg/ml) were incubated with or without
10 lg/ml LPS for 2 h at RT and washed with endo-
toxin-free water as described. After two washings,
LPS-coated and uncoated Au NPs were resuspended
in 500ll of human plasma either undiluted (100%) or
diluted in PBS at 10% or 55%. After 4 h at 37 C, the
NPs were centrifuged at 14000g for 10min at 4 C,
the pellets were resuspended in PBS, washed twice
and resuspended in 90 ll PBS. Then 30 ll 4 Laemmli
sample buffer (Bio-Rad Laboratories, Inc., Hercules,
CA, USA) were added and incubated at 95 C for
5min. An equal sample volume (10ll) was loaded in
4%-12% polyacrylamide gel (Mini-PROTEANVR TGXTM
precast gels, Bio-Rad Laboratories, Inc.). Gel electro-
phoresis was performed at 120 V for 60min. The gels
were stained with the Coomassie brilliant blue R-250
staining solution (Bio-Rad Laboratories, Inc.) for 2 h
and destained overnight with the Coomassie brilliant
blue R-250 destaining solution (Bio-Rad Laboratories,
Inc.). Gel density was analyzed by image J.
CytoViva characterization of LPS binding on the
Au NP surface
For analysis of LPS binding to the Au NP surface,
optical and hyperspectral imaging analysis were
acquired with a dark field-based optical illumination
system from CytoViva (CytoViva Inc., Auburn, AL,
USA). Au NPs and LPS-coated Au NPs were applied
to a slide and covered with a coverslip (Carl Roth
GmbH Co KG, Karlsruhe, Germany). The measure-
ment is based on the characteristic scattering profile
of Au NPs. Each pixel of the image was recorded at a
wavelength of 400-1000 nm, and was automatically
compared by the classification algorithm spectral
angle mapper (SAM) to the LPS-coated Au NPs. The
data is presented as normalized mean region of
interest (ROI) of 1,100 LPS-coated Au NPs normalized
to the mean ROI of 1,100 Au NPs.
Limulus amoebocyte lysate (LAL) assay
The endotoxin contamination of Au NPs was meas-
ured with the chromogenic LAL assay PyrochromeVR
(Associates of Cape Cod, Inc., East Falmouth, MA,
USA) or QCL-1000TM (Lonza Group Ltd., Basel,
Switzerland), following the manufacturers’ instruc-
tions. A newly established protocol for testing endo-
toxin in interference-free conditions was used (Li
et al. 2015). Evaluation was performed on at least 3
different concentrations of NPs, previously tested
for lack of interference with the assay’s optical read-
out, and which had an acceptable value of recovery
rate (assessed by running the positive product con-
trols that evaluate the NP interference with the
assay components). Briefly, 50 ml NPs dilutions were
mixed with 50 ml LAL in 96-well plate, and incu-
bated for 30min or 10min at 37 C followed by
addition of 50 or 100 ml substrate solution. After
incubation for 6-10min at 37 C, 100 ml of the stop
reagent (acetic acid, 25%v/v in water) was added to
each well. For the PyrochromeVR assay, the diazo
reagents (100 ml in total) were applied to generate
azo dye and shift the detection wavelength from
405 nm to 540 nm (to avoid the potential readout
interference by NPs). Absorbance was measured at
405 nm or 540 nm with a plate reader (Tecan,
Groedig, Austria) and was compared with the endo-
toxin standard curve (1 endotoxin unit [EU] approxi-
mately corresponding to 0.1-0.2 ng LPS).
Agent-based model (ABM) of interaction between
LPS and Au NPs
We used NetLogo 5.3.1 (Netlogo 2014), a platform
with a simplified programing environment, easily
implemented tool sets, and well-established docu-
mentation support, to implement this ABM (Shi, Wu,
and Ben-Arieh 2014; Shi et al. 2016). The primary
user interface of NetLogo is comprised of two-
dimensional (2 D) grids, in which agents can be div-
ided into two categories: “patches” and “turtles.”
“Patches” are fixed agents placed on background
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grids in the model workspace. “Turtles” are mobile
agents that can occupy a position or move freely
on the surface of patches and execute certain func-
tions or actions regulated by the simulated system
(Shi et al. 2016). The interface of NetLogo allows a
modeler to set initial parameters and observe simu-
lation results. Both LPS and Au NPs are “turtles” in
this simulation. The ABM was conducted on a high-
end desktop (technical specification: DELL Intel
i7-4790 3.6 GHz with 16GB of RAM).
Estimated mathematical relationship between SPR
peak red-shift and the amount of LPS bound to
Au NPs
Estimation of a mathematical relationship between
the SPR peak of the UV-VIS spectrum and the
amount of bound LPS on Au NPs was performed
with the MATLAB software, using the Curve Fitting
Toolbox. To estimate the amount of LPS bound to
Au10CIT resulting in a SPR red-shift, a simulation
was performed based on the observation that, at
the LPS concentration of 10 mg/ml, binding to
Au10CIT was saturated within 2min. On this basis,
6,423 steps were calculated in the in silico simula-
tion runs, corresponding to the 2min saturation
time in the above experiment.
Human monocyte isolation
Human peripheral blood mononuclear cells (PBMC)
were separated from buffy coats of healthy donors
by centrifugation with Ficoll-Paque PLUS (GE
Healthcare, Bio-Sciences AB, Uppsala, Sweden).
CD14þ monocytes were isolated from PBMC using
the Monocyte Isolation kit II (Miltenyi Biotec,
Bergisch-Gladbach, Germany) according to the man-
ufacturer’s protocol. The purity of the isolated
monocytes (>98%) was determined by differential
counts on cytocentrifuge smears stained with a
modified Wright-Giemsa dye (Diff QuikVR , Medion
Diagnostics AG, D€udingen, Switzerland). Viability
was determined by trypan blue dye exclusion and
always exceeded 98%.
Monocyte activation test (MAT)
Monocytes were cultured at a density of 2.5 106
cells/well in 12-well culture plates (CostarVR , Corning
Inc.; New York, NY, USA) in 1ml of RPMI
1640þGlutamax-I medium (GIBCOVR by Life
Technologies, Paisley, UK) supplemented with
50 lg/ml Gentamicin (GIBCOVR ), 5% heat-inactivated
human AB serum (Lonza Group Ltd.) at 37 C in
moist air with 5% CO2.
LPS-coated/-uncoated Au NPs were preincubated
with 100% heat-inactivated human AB serum and
incubated for 4 h at 37 C before addition to cells in
culture. LPS-coated Au NPs were added to mono-
cytes in culture at final concentrations between 0.25
and 2 cm2/ml. After 18 h, supernatants and cells
were collected for analysis of protein production
and gene expression.
Activation of NFjB-responsive reporter cells
Human embryonic kidney (HEK) 293 cells (Sigma-
Aldrich Inc.) were plated at a density of 1.2 105
cells/well of 24-well plates (Corning Inc.) in 500 ml
Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-
Aldrich Inc.) supplemented with heat-inactivated
10% fetal calf serum (FCS), 2mM L-glutamine and
2mM nonessential amino acids (NEAAs), 100U/ml
penicillin and 100mg/ml streptomycin. On the next
day, the cells were transfected using the
Lipofectamine 2000 reagent (Invitrogen, Life
Technologies) according to the manufacturer’s
instructions. Briefly, 1.5ml Lipofectamine 2000
reagent and a set of plasmid DNAs were diluted in
25 ml Opti-Mem (GIBCOVR ) per well. The plasmids
used were pGL3Neo-NFjB-LUC (400 ng; kindly pro-
vided by Min Li-Weber (Li-Weber, Giasi, and
Krammer 1998)), pCDNA3-CD14 (20 ng), pEFBOS-
MD2 (20 ng), and pCDNA3-TLR4 (60 ng) (all kindly
provided by Andrei Medvedev and Douglas
Golenbock). The reactions were mixed, pooled, and
incubated for 5min at RT. After the incubation,
50 ml of the transfection mix were added to the
wells. On the next day, the medium was filled up to
1ml and cells were exposed to different concentra-
tions of LPS, Au NPs, and LPS-coated Au NPs. LPS
coating was obtained by incubating 1ml of Au40
CIT NPs (3.5 1010 NPs) with 50 ng LPS overnight at
4 C, and then collecting NPs by centrifuging
3 5min at 18000 rpm to remove unbound LPS.
After 24 h, the supernatants were collected and
stored at 80 C for cytokine ELISA, and cells were
lysed with 100 ml/well of lysis buffer (100mM
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potassium phosphate pH 7.8, 0.1% Triton X-100,
1mM dithiothreitol). The lysates were transferred to
white polystyrene flat-bottom microtiter plates
(Greiner Bio-One, Kremsmuenster, Austria), and the
luciferase activity was measured with a plate reader
(Tecan), after addition of 50 ml of luciferase substrate
per well.
RNA extraction and quantitative real-time
polymerase chain reaction (RT-PCR) analysis
RNA was extracted by using Qiagen miRNeasy kit
(Qiagen, Hilden, Germany) and quantified by ND-
1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA). The RNA integrity was checked
by microcapillary electrophoresis on Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, USA) on
the basis of the ratio between 28 S and 18 S rRNA
peak areas and of the RNA integrity number (RIN, >8)
index. RNA samples were stored at 80 C until use.
cDNA was reverse-transcribed from total RNA
(300 ng per sample) with oligo-dT and random pri-
mers, according to the QuantiTect Reverse
Transcription Kit (Qiagen) instructions. Two to three
separate reverse transcriptions were performed for
each sample, and an identical reaction without
reverse transcriptase was run as the negative con-
trol. Taqman quantitative PCR was performed with a
Rotor-GeneTM 3000 (Corbett Research, Doncaster,
Victoria, Australia), using the QuantiTect SYBR Green
PCR Master Mix (Qiagen). The final reaction con-
tained 12.5 ll 2x Master Mix, 0.3lM of each primer,
and 2.5ll of cDNA in a total volume of 25 ll. PCR
conditions were 94 C for 15min, followed by 35-40
cycles of 94 C for 15 s, 50-60 C for 30 s, and 72 C
for 30 s. Primer sequences were supplied by Qiagen
both for target genes (IL1B, IL1RN) and housekeep-
ing genes (ACTB). Relative gene expression was cal-
culated using the efficiency correction method,
which calculates the relative expression ratio from
the quantitative PCR (qPCR) efficiencies and the Ct
between the target gene and the endogenous con-
trol, relative to a calibrator sample (Pfaffl 2001).
Protein detection by ELISA
Human IL-1b and IL-1Ra were measured in the cell
culture supernatants by ELISA with commercially
available kits (R&D Systems, Inc., Minneapolis, MN,
USA). Human IL-8 was measured by Human IL-8
Standard ELISA Development Kit from PeproTech
(Rocky Hill, NJ, USA). Each sample was assayed in
duplicate, and detection was performed with a
microplate spectrophotometer (Tecan).
Statistical analysis
The results are expressed as mean± standard devi-
ation (SD) of 3 independent experiments, calculated
using MicrosoftVR Office Excel 2007 and analyzed
using GraphPad Prism (GraphPad Software Inc.,
USA). Statistical analysis was performed using a
one-way analysis of variance (one-way ANOVA) and
a Tukey’s post hoc test, or F-test and Student’s t-test
(as appropriate). p-Values <0.05 were regarded as
statistically significant.
Ethics statement
No ethical approval or informed consent is required
by the Italian law for discarded blood products. The
use of the blood samples from anonymous healthy
donors for the MAT was approved by the Ethical
Committee of the University of Pisa S. Chiara
Hospital (prot. AOUP 33998 of Sep. 29, 2006).
Result
Characteristics of Au NPs
Six different types of Au NPs were used in this study
with different sizes and with different surface coat-
ings. Sodium citrate-coated 10 nm and 40-60 nm Au
NPs (Au10CIT and Au40CIT), lipoic acid-coated 40 nm
and 80 nm Au NPs (Au40LIP and Au80LIP), 40 nm Au
NPs coated with branched polyethyleneimine
(Au40BPEI), and with polyethylene glycol Au NPs
(Au40PEG) (Figure 1 and Table 1). The endotoxin con-
tamination levels of these Au NPs were determined
to be less than 2.5 EU/ml in their stock solutions (with
contamination in Au10CIT as low as 0.45 EU/ml),
except for the commercial Au40CIT that had an endo-
toxin contamination of 20 EU/ml (Table 1).
In the attempt of understanding whether and up
to what extent endotoxin binds to the surface of
NPs, and if the endotoxin on the NP surface may
trigger inflammation, we performed a series of
experiments for assessing both the features of
endotoxin adsorption on the Au NPs surface and its
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capacity to interfere with the formation of a biomo-
lecular corona in biological fluids (plasma), with the
final goal of assessing the role of endotoxin
adsorbed onto NPs in triggering inflammatory
responses in human monocytes in vitro, a reliable
and representative model system to assess the
immunotoxic effects of NPs (Li et al. 2016).
Bacterial endotoxin can bind to the surface of
Au NPs
Au10CIT were incubated with different concentra-
tions of E. coli LPS at RT. A discrete red-shift of the
SPR peak of the UV-VIS spectrum of few nm was
observed, which indicates the binding of LPS to the
Au NP surface (Figure 2). Since the citrate coating is
loosely attached to the surface of Au NPs, it is easily
replaced by other molecules in the solvent having
higher affinity for the NP surface. Thus, once LPS
was added, the replacement was already evident in
minutes, and seemed to reach a fairly stable condi-
tion in less than 1 h, with some peak vibrations
observed afterwards and a tendency to increase at
1 and 3.3mg/ml (Figure 2). Moreover, the increase in
NP diameter and the decrease in Z-potential (Figure
3, center and right panels) indicated a dose-depend-
ent binding of LPS onto the Au NP surface, which
increased rapidly in the first 2 h (Figure 3 left panel,
see also Figure 2), then slowly until 24 h and
became apparently stable afterwards. After 24 h, the
stability of the UV-VIS signal indicated a saturated
Au NP surface (Figure 3, left panel), while the evolu-
tion of the DLS and Z-potential signals would indi-
cate compaction and reorganization of the LPS
coating layer (Figure 3, center and right panels). No
aggregation of the NPs was observed during the
course of the experiments. To further confirm that
LPS can attach to the surface of 10 nm Au NPs, the
Au10CIT were washed (centrifugation/resuspension)
with endotoxin-free pure water. Unsurprisingly, the
Figure 2. UV-VIS surface plasmon resonance spectrum red-shift of Au NPs after exposure to different concentrations of LPS.
Au10CIT were incubated with different concentrations of E. coli LPS. Au NPs were characterized by UV-VIS at 2min intervals for
2 h. The red point at time zero represents the value of untreated NPs.
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presence of LPS on the NP surface stabilized them,
as they did not aggregate after the washing, in con-
trast to LPS-free sodium citrate-stabilized NPs that
showed significant aggregation after resuspension
in endotoxin-free water (Figure S1). These results
confirm that the endotoxin is adsorbed on the sur-
face of Au NPs.
The adsorption of LPS onto the surface of larger
particles was tested by incubating Au40CIT with LPS.
As shown in Figure 4, the presence of a saturated
layer of LPS bound to the NP surface (defined as LPS
corona) was verified by DLS and CytoViva. The diam-
eter of the LPS-coated Au NP, measured by DLS,
increased compared to the untreated Au NPs (Figure
4, left and center). The optical and hyperspectral
imaging showed a clear wavelength shift upon LPS
binding to the NPs (Figure 4, right panel).
To examine how different surface functionaliza-
tion may change the LPS adsorption, the binding of
LPS to 40 nm and 80 nm Au NPs coated with depro-
tonated lipoic acid (Au40LIP and Au80LIP) was eval-
uated. Au40LIP and Au80LIP were incubated with
different concentrations of LPS and their diameters
were monitored over time as shown in Figure S2.
A LPS dose-dependent NP size increase was
observed, which occurred rapidly within 2min after
addition of LPS. It is likely that LPS at low concen-
trations cannot easily displace the tightly attached
lipoic acid from the NP surface. The LPS coating
with Au40LIP was also evident in the TEM micro-
graphs (Figure S3).
Computational simulation and mathematical
relationship between LPS and Au NPs
LPS binding to the surface of Au NPs was further
studied by computational simulation in order to
evaluate the quantitative relationship between LPS
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and Au NPs, and the correlation of the UV-VIS SPR
red-shift with the amount of LPS attached to the NP
surface. An agent-based model (ABM) was applied
to simulate the interactions between LPS and Au
NPs in silico (Bonabeau 2002; Bachman and Sorger
2011). The simulation interface was a 601 601 2D
grid generated in NetLogo, which was designed to
simulate an environment of binding between LPS
and Au NPs. Au NP number was initialized to 5
counts upon consideration of computational cap-
ability. LPS numbers were adjustable based on vari-
ous LPS concentrations and Au NP numbers.
Considering an average molecular weight (MW) for
LPS of about 20 kDa and the nominal average dens-
ity of LPS of 1.44 g/cm3 (see Supporting Information
reference 2), a 10 nm2 LPS fingerprint was calculated
(supporting info, Table S1, Figures S4 and S5).
Therefore, the number of LPS molecules on the sur-
face of a single 10 nm Au NP at saturating concen-
trations is 628 (see Supporting Information). In this
simulation, it is assumed that the movement of LPS
and Au NPs follows pure Brownian motion and
therefore the movement for each LPS and Au NPs
was updated per simulation step based on a uni-
form distribution with a range of (0, 360). Likewise,
at each simulation step, the locations of LPS and Au
NPs were updated based on the direction and mov-
ing step. The binding process occurs when a LPS
molecule and an Au NP (or LPS-Au NP complex)
occupy the same location in the simulation inter-
face. At that specific location if on the Au NP sur-
face there is room for binding (as stated above,
assume one 10 nm Au NP can bind a maximum of
628 LPS molecules), the free LPS molecule will bind
to this specific Au NP. Otherwise, LPS will move
away to meet the adjacent Au NP. Once LPS binds
to an Au NP, an LPS-Au NP complex is formed and
the two entities move simultaneously in the next
simulation step. The simulation terminates once all
the Au NPs reach their maximal binding capacity
(surface saturation). Thirty replicated runs for each
LPS concentration were performed in silico and a
statistical analysis was conducted using the software
R 3.1.2 (https://cran.r-project.org/bin/windows/base/
old/3.1.2/). As depicted in Figure 5 (upper panel), a
correlation was observed between the initial LPS
concentration and the saturation time (p< 0.05),
which is consistent with the experimental observa-
tions in Figure 2. A video was produced in Netlogo,
simulating the binding process between LPS and Au
NPs (see Supporting Materials, videos 1 and 2). A
statistically significant correlation was found
between the SPR red-shift of the UV spectra of the
formed LPS-Au NP complexes and the amount of
bound LPS (Figure 5 lower panel). This indicates
that the experimental data on red-shift are statistic-
ally correlated (Sum Square Error: 1.255e-6, R-
square: 0.8304, adjusted R-square: 0.8304, root-
mean-square deviation: 0.0004573) to the following
the Langmuir absorption isotherm:
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Figure 5. Computational simulation and mathematical rela-
tionship between LPS and Au NPs. Upper panel: Agent-based
model (ABM) simulation between LPS and Au10CIT in silico.
Lower panel: A mathematical relationship between the meas-
ured UV-VIS surface plasmon resonance (SPR) peak red-shift
(red dots) and simulated amount of LPS bound on the surface
of Au NPs was estimated using the Curve Fitting ToolBox in
MatLab. On the Y axis is reported the relative peak shift
(defined as SPR peak red-shift/maximum SPR peak red-shift).
The maximum SPR red-shift was 520 nm in our experiments.
The X axis is the amount of LPS bound onto Au NPs that was
acquired in silico. The estimated curve follows a Langmuir
absorption isotherm.
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In the equation above, k represents SPR red-shift
and kmax represents the maximum observed SPR
red-shift (520 nm in our experiments). LPS denotes
the amount of LPS bound onto the NP surface in sil-
ico, and Kk is an equilibrium constant for LPS bind-
ing to the NP surface. Using the Curve Fitting Tool
in MATLAB, the estimated Kk is 0.6267 (with 95%
confidence limits of 0.4926, 0.7608).
Surface coating of Au NPs affects LPS binding
Binding of LPS was also assessed on Au NPs coated
with different molecules, in addition to lipoic acid.
Au40BPEI and Au40PEG were exposed to LPS at RT
for different times and LPS binding was assessed by
DLS in comparison with Au40LIP. As shown in
Figure 6, only the Au40LIP showed a size increase
upon LPS treatment, but no increase in size or vari-
ation was evident for Au40BPEI or Au40PEG over
one week of incubation with LPS. These results
show that different surface coatings can allow or
avoid LPS binding to the NP surface. Highly soluble
and large molecules such as PEG and BPEI provide
steric repulsion to the NP surface preventing LPS
binding, whereas lipoic acid (a stiff small molecule
with hydrophilic and hydrophobic domains that
makes dense self-assembled monolayers onto the
NP surface) does not provide steric repulsion and
therefore allows for the binding of LPS.
LPS coating interfere with biomolecular corona
formation on the Au NP surface
Formation of a biomolecular corona on the NP sur-
face, upon interaction with biological fluids, is very
important in determining the NP biological effects
in vitro and in vivo (Casals et al. 2010; Monopoli
et al. 2011; Salvati et al. 2013). Therefore, we investi-
gated whether the presence of LPS (as uninten-
tional contaminant) on the NP surface could alter
the interaction between NPs and proteins and other
molecules present in biological fluids. In Figure S6,
the mean size of Au NPs in the presence or absence
of LPS coating did not vary much after incubation
in human plasma, but differences could be detected
in the size distributions of LPS-coated vs. uncoated
NPs, and these differences can be attributed to a
stabilizing effect of LPS on NPs (as suggested by
the data in Figure S1), and by the different proper-
ties of the NP-biomolecule complex.
We further analyzed if the LPS coating could
affect the formation of a stable hard corona on the
surface of NPs in vitro. The results shown in
Figure 7 indicate a smaller increase in the size of Au
Au40LIP
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NPs if the particles were pre-coated with LPS.
Furthermore, the SDS-PAGE analysis showed a sig-
nificant decrease in the biocorona formation on the
surface of LPS-coated Au NPs, this finding being
particularly evident upon incubation with undiluted
human plasma (100%). It is apparent that many low
MW proteins did not attach to the surface of LPS-
coated Au NPs. This is consistent with the DLS size
distribution data in Figure S6 which showed the
small peak (possibly representing the low MW pro-
teins) disappearing in LPS-coated Au NPs. Thus, the
LPS coating, like PEG and BPEI, seems to make par-
ticles unable to adsorb plasma biomolecules in a
stable fashion, likely by steric hindrance.
LPS coating on Au NPs induces inflammatory
responses in vitro
LPS has potent inflammatory effects in vivo and in
vitro, and activates innate/inflammatory cells, such
as monocytes and macrophages, mainly through
the TLR4 signaling pathway, a key mechanism of
the defensive inflammatory response against bac-
teria (Janeway and Medzhitov 2002, Murphy 2012).
Therefore, the ability of LPS-coated Au NPs to
induce inflammatory activation was tested in human
primary monocytes in vitro. Results in Figure 8
showed that LPS-coated Au10CIT induced the
expression of the IL1B gene and the production of
the mature IL-1b protein, suggesting that LPS-
coated NPs not only upregulate the IL1B gene but
could also activate the inflammasome-dependent IL-
1b maturation (Latz 2010). LPS-uncoated Au10CIT
were unable to induce either IL1B gene expression
or IL-1b protein production. It was interesting to
see that free LPS could induce, as expected, the
expression of the IL1RN gene and the production of
the anti-inflammatory cytokine IL-1Ra, the receptor
antagonist of IL-1b (Figure 8). However, the LPS-
coated Au10CIT had little to no effect on both the
IL1RN gene expression and IL-1Ra production, simi-
larly to the uncoated Au10CIT (Figure 8, right pan-
els). Thus, LPS-coated Au10CIT seem to display
similar effects as free LPS in terms of inflammatory
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cytokine production. However, this was not com-
bined with the concomitant induction of anti-
inflammatory effects. The differences in the mecha-
nisms of IL-1 vs. IL-1Ra induction by LPS are still
unexplored and are an area of ongoing research. In
any case, we have evidence that, at the time point
under study, LPS bound onto the NP surface can
induce an inflammatory cytokine but not its anti-
inflammatory inhibitor, thus LPS-coated Au NPs rep-
resent a new entity with an activity profile that is
different from those of the two components. It is
important to mention that both LPS-coated and
uncoated NPs in these experiments were incubated
with human serum to allow for the corona forma-
tion before administering them to the monocytes in
culture. Thus, the different biological effects and
activity profiles between LPS-coated and uncoated
NPs should include their different capacity of form-
ing a biomolecular corona.
This observation was extended by testing the
cell-activating capacity of LPS-coated and uncoated
Au40CIT. Since these commercial NPs are contami-
nated with endotoxin, we decided to test them on
a specifically designed LPS–responsive reporter cell
line, which shows a dose-dependent reactivity to
LPS that does not go into saturation at such LPS
concentrations as in the case of primary human
monocytes (exquisitely sensitive to LPS (Schwarz
et al. 2014; Li and Boraschi 2016)). With this cell
line and with an extensive dose-response experi-
ment, it should be possible to distinguish between
activation due to the original LPS contamination
Figure 8. LPS-coated Au NPs induce inflammatory activation of human monocytes. Au10CIT were incubated with 200 ng/ml of
LPS for 1 h. Unbound LPS was washed off, and the effects of LPS-coated Au NPs were assessed on human primary monocytes after
18 h incubation, in comparison with those triggered by 1 ng/ml LPS. Upper panels: expression of IL1B and IL1RN genes. Lower pan-
els: production of the IL-1b and IL-1Ra cytokines. The results are the mean± SD of data obtained from one experiment representa-
tive of 3 performed. p< 0.05, p< 0.01 (LPS-coated vs. uncoated NPs).
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and that induced by LPS intentionally adsorbed
onto the NP surface. This system is based on a
transient co-transfection of HEK 293 cells with
plasmids encoding the various molecules of the
LPS receptor (TLR4, CD14, MD2) and with a
reporter plasmid with the luciferase (LUC) gene
under the control of an NFjB-responsive promoter.
The transiently transfected cells were exposed to
free LPS, Au40CIT and the LPS-coated Au40CIT for
24 h. The concentrations of free LPS used in this
assay were set to match the amount of LPS used
for coating the Au40CIT NPs. Data in Figure 9
show the response of transfected HEK 293 cells to
LPS-coated NPs is greater than that to uncoated
NPs both in terms of NFjB activation and the
induction of the inflammatory chemokine IL-8.
Note that the uncoated NPs induced a response,
as expected because of the initial contamination
of these NPs with endotoxin. In fact, the extent of
activation induced by contaminated NPs compares
quite well with the response induced by corre-
sponding LPS concentrations (the initial particle
contamination roughly corresponds to 0.002, 0.02,
0.1, 0.2 and 0.5 ng/ml, as determined by the LAL
assay). Hence, no difference occurred in the
activation capacity of LPS, either free or bound to
NPs, at least in terms of NFjB activation and IL-8
production.
Discussion
The biological effects of engineered nanomaterials
are a topic of considerable debate and important
for nanomaterials’ safety assessment. Contamination
of NPs with bioactive molecules can significantly
alter the NP biological effects. Therefore, it calls for
the need of determining the type and grade of con-
tamination, in order to define the true nano-effects
(Dobrovolskaia et al. 2008). Despite the fact that
nanomaterials have a tendency to interact with dif-
ferent biomolecules, studies determining the con-
tamination of nanomaterials with different bacterial
substances are limited. Endotoxin (LPS), an ubiqui-
tous thermo-resistant toxin of bacterial origin, can
cause various life-threatening diseases at low doses
and can easily contaminate NPs, if the synthesis
conditions are not well-controlled or handling proc-
esses are not adequately performed (Li and Boraschi
2016). In this study, the capacity of LPS to bind to
the surface of Au NPs and how the presence of LPS
Figure 9. Activation of reporter HEK293 cells with free vs. NP-bound LPS. HEK293 cells transiently overexpressing TLR4, CD14, and
MD2 were transfected with an NFjB-responsive LUC reporter gene. Left panel: NFjB activity was measured in response to free
LPS, to LPS-coated Au40CIT NPs (the amount of LPS used for coating is indicated), and to the corresponding number of NPs.
NFjB activity was assessed by measuring LUC-dependent light emission. Right panel: Release of IL-8 in response to the same stim-
uli was detected by ELISA in the culture supernatants. Results are expressed as fold increase vs. the value in untreated cell cultures
(¼ 1; indicated as dotted horizontal line), and presented as mean± SD of 3 independent experiments. Values were compared to
the respective concentration, p< 0.05, p< 0.001, p< 0.0001.
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may alter the biological effects of NPs was
investigated.
NP surfaces adsorb a wide range of molecules
from the surrounding milieu to reduce their free
energy, due to the highly reactive nature of their
surface (Li and Boraschi 2016). Endotoxin is one of
the unintentional contaminants that can be present
on the surface of nanomaterials. In this study, LPS
can easily bind to the surface of sodium citrate and
lipoic acid coated Au NPs, and this binding capacity
appears to be rapid and strong. For example, in the
case of Au10CIT, the UV-VIS SPR peak red-shift
results (Figure 2) indicate that binding of LPS occurs
after 2min at RT and reaches stability after approxi-
mately 1 h. The LPS-binding capacity appeared to
be dose-dependent but temperature-independent,
displaying essentially similar binding kinetics at 4 C,
representing the storage conditions, and 37 C, rep-
resenting biological conditions (data not shown).
The corona formed by LPS on Au NPs was visualized
by TEM (Figure S3).
Different coatings were investigated for Au NPs
in this study, including sodium citrate, lipoic acid,
BPEI, and PEG, which determine differences in sur-
face chemistry, charge, and steric conditions. The
interaction between citrate anions and the surface
of Au NPs is weak, which makes it easy replacing
the citrate ions with other molecules in the milieu,
such as LPS. The binding of LPS was also observed
on Au NPs with a tight coating, such as lipoic acid,
which is deprotonated (negatively charged) at
physiological pH (Figure S2 and S3). Lipoic acid
forms a dense self-assembled “hard” monolayer
onto the NP surface. However, when using BPEI
(positively charged at physiological pH) or PEG
(neutral), no LPS absorption was observed, consist-
ent with the reason why these molecules are used
to avoid NP opsonization (Owens and Peppas 2006).
Note that the differences in surface charge were
not as important as the steric repulsion provided by
the polymeric coating molecules. Surface charges
have relevance in physiological media, due to the
presence of high electrolyte concentrations, there-
fore they are expected to have an effect on the NP-
LPS aggregation rate but not a fundamental effect
on the formation of a biomolecular corona. Thus,
from these results, it is evident that LPS binding to
NPs varies depending on the surface coating and
charge.
In the attempt to understand the quantitative
relationship between LPS and Au NPs, and the cor-
relation of the SPR red-shift with the amount of LPS
binding to the Au NPs surface, ABM was applied to
simulate in silico the interactions between LPS and
Au NPs. ABM inherently captures repetitive spatial
interactions between agents in a stochastic process
or under a known probability distribution, making it
a powerful tool to render valuable information and
simulate a complex system. Monitoring the SPR
red-shift by time until Au NPs reached binding
saturation was found to depend on the initial LPS
concentration, a finding consistent between the
ABM and our experimental data. After calibrating
the mathematical relationship between UV-VIS SPR
red-shift and the amount of LPS bound on Au NPs,
using simulated and experimental data, a mathem-
atical relationship was obtained that followed a
Langmuir absorption isotherm. This finding further
demonstrates that LPS-binding quantitatively corre-
lates with the SPR red-shift of Au NPs.
The biomolecular corona that forms on the sur-
face of NPs upon interaction with biological fluids is
a very important phenomenon that affects the bio-
logical behavior of NPs (Lundqvist et al. 2008; Casals
and Puntes 2012). Here, we have examined the for-
mation of the biocorona onto NPs that have been
contaminated with LPS, a molecule consisting pri-
marily of lipids, carbohydrates, and importantly,
being ubiquitous in nature and a common contam-
inant of NP preparations (Vallhov et al. 2006; Li and
Boraschi 2016). It is reasonable to think that the LPS
coating can interfere with a subsequent corona for-
mation with molecules coming from biological flu-
ids in in vitro or in vivo conditions. In this regard,
we have investigated how the LPS coating on Au
NPs could lead to anomalies in the formation of the
biomolecular corona. We showed that the LPS coat-
ing on Au NPs has significant effects on size distri-
bution after incubation with human plasma at 37 C
(Figures 7 and S6). This suggests that the presence
of LPS on the NP surface causes a decrease of the
available surface area and its free energy, thereby
decreasing the interaction with plasma molecules.
This also indicates a strong adherence of LPS to the
NP surface and the inability of plasma molecules to
displace it. By analyzing the amount and compos-
ition of proteins forming the biomolecular corona
on the NP surface by SDS-PAGE, we showed that
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the formation of the biocorona decreased signifi-
cantly in LPS-coated vs. LPS-uncoated Au NPs
(Figure 7). In addition, it seems the biocorona that
forms on the surface of LPS-coated NPs preferen-
tially contains high MW proteins, since apparently
many low MW proteins were unable to attach to
the LPS-coated NP surface. This implies that the bio-
logical properties of NPs can significantly change
consequent to the change in the biocorona com-
position. This limited availability of the NP surface,
due to the presence of LPS, may be of concern in
preclinical studies for biomedical applications, as
the unintentional presence of LPS in NP prepara-
tions may affect surface functionalization and conse-
quent efficacy of nanodrugs. Therefore, the
unwanted binding of LPS on the surface of NPs
interferes with the formation of a biocorona,
thereby causing additional variations in biological
effects. Thus, the adsorption of LPS on the NP sur-
face can be considered as an unintended modula-
tion of the NP surface properties.
The inflammatory activity of LPS is mainly due
to activation of the TLR4 signaling pathway in
innate immune cells. Upon TLR4 activation, cells
produce many inflammatory factors, including IL-
1b, a key inflammatory and immunostimulating
cytokine (Dinarello 2009; Dinarello 2011; Joosten,
Netea, and Dinarello 2013) and, as feedback
mechanism, also anti-inflammatory factors such as
the IL-1 inhibitor IL-1Ra. Since it is likely that an
unintentional presence of LPS on the NP surface
may lead to acquisition of LPS-dependent inflam-
matory effects, we studied how the presence of
LPS coating may affect the biological effects of
NPs. This was done by examining the ability of
LPS-coated NPs to induce an inflammatory reac-
tion in human monocytes in vitro. The results in
Figures 8 and 9 show that the LPS coating could
induce/increase significantly the inflammatory
effects of Au NPs. This implies that the presence
of LPS may lead to misinterpreting results con-
cerning nanomaterial inflammatory potential, as
LPS may be the sole responsible of the inflamma-
tory response often attributed to NPs in in vitro
and in vivo nanosafety studies in which the pres-
ence of LPS contamination was not assessed.
However, while LPS-coated NPs could induce LPS-
like inflammatory responses such as NFjB activa-
tion and expression/production of inflammatory
cytokines such as IL-1b and IL-8, it is notable that
LPS-NPs were unable to reproduce the LPS-
induced induction of anti-inflammatory mecha-
nisms such as the expression/production of the IL-
1 inhibitor IL-1Ra. The fact that LPS-coated NPs, at
variance with free LPS, were unable to activate
the anti-inflammatory feedback mechanisms (aim-
ing at resolving inflammation in the context of a
normal defensive response) suggests that adsorp-
tion of LPS on the NP surface alters its structure
and/or orientation in a fashion that allows main-
taining its inflammation-inducing capacity but that
eliminates its inflammation-resolving effects. While
there is no data discriminating between the two
LPS activities in terms of receptor-binding modes,
it should be noted that activation by LPS can
occur in complex ways, with optimal activation
involving soluble LBP and MD2, membrane TLR4
and CD14, and receptor clustering, but that acti-
vation can be obtained also in the absence of
one or more of the co-receptor molecules. That
LPS-coated NPs have the same inflammatory cap-
acity of free LPS was confirmed also with a
reporter cell-based system. These data imply that
the altered biocorona does not influence the
induction of LPS-mediated inflammation. On the
other hand, it is possible that differences in the
biocorona may take part in the inability of LPS-
coated NPs to induce LPS-like anti-inflammatory
activation. Overall, this means that LPS-coated Au
NP represents new entities with an activity profile
that is different from those of the two compo-
nents, and in which the effects of LPS can be
exacerbated.
Conclusion
In this study, the binding capacity between LPS, a
bacterial-derived ubiquitous contaminant, and Au
NPs was examined. The binding of LPS to the sur-
face of Au NPs was significant and varied according
to the NP surface functionalization. Coating with
either citrate or lipoic acid (small molecules) allowed
the formation of a stable LPS coating, whereas coat-
ing with bulky molecules such as BPEI and PEG pro-
vided enough steric repulsion to avoid LPS-binding.
LPS-coated NPs have at least two characteristics
that differ from uncoated NPs: the presence of LPS
on their surface, and an anomalous biocorona,
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composed by lower amounts of proteins, preferen-
tially of high MW. How these changes influence the
biological effects of NPs was tested on human pri-
mary monocytes and on transfected HEK 293
reporter cells in vitro. The data obtained suggest
two conclusions. First, that non-inflammatory NPs
may acquire inflammation-inducing capacity just by
adsorbing LPS onto their surface. Second, that LPS-
coated NPs are new entities, with a functional pro-
file that differs from those of the two components.
In particular, LPS-coated NPs appear to maintain the
capacity of LPS to induce inflammatory responses
(NFjB activation, expression and production of IL-1b
and IL-8) but lose the ability of LPS to activate
inflammation-resolving mechanisms (expression and
production of the anti-inflammatory cytokine IL-
1Ra).
These data suggest that unintentional adsorption
of endotoxin to engineered NP surface can signifi-
cantly affect the biomolecular corona formation and
inflammatory/immunotoxic effects and, if going
undetected, may lead to erroneous interpretation of
nanotoxicity data. Distinguishing the true NP effects
from those caused by biologically active contami-
nants such as LPS is key to a correct and reliable
nanosafety and nano-bio-interaction evaluation.
Another important conclusion is that adsorption of
bioactive contaminants, such as LPS, from the envir-
onment, exposes human beings and environmental
living species to new entities with a toxic potential
that cannot be predicted from the toxicity of the
individual components.
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